A Phase II Trial of Revlimid, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Active Multiple Myeloma.
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Lenalidomide (Primary) ; Cyclophosphamide; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 07 Jun 2016 Results of a retrospective analysis (NCT01864018; n=51 and NCT00478218; n=53) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 29 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 May 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.